Кето-диета. Революционная система питания, которая поможет похудеть и «научит» ваш организм превращать жиры в энергию

37. G. L. Austin et al., “A Very Low-Carbohydrate Diet Improves Gastroesophageal Reflux and Its Symptoms,” Digestive Diseases and Sciences, 51, no. 8 (August 2006): 1307–1312, DOI: 10.1007/sl0620-005-9027-7.

38. Singh et al., “Weight Loss Can Lead to Resolution of Gastroesophageal Reflux Disease Symptoms.”

39. G. L. Austin et al., “A Very Low-Carbohydrate Diet Improves Symptoms and Quality of Life in Diarrhea-Predominant Irritable Bowel Syndrome,” Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association, 7, no. 6 (2009): 706–708. el. DOI: 10.1016/j. cgh.2009.02.023.

40. Z. Zheng et al., “Staple Foods Consumption and Irritable Bowel Syndrome in Japanese Adults: A Cross-Sectional Study,” PLoS One, 10, no. 3 (2015): eOl 19097, DOI: 10.1371/journal.pone.Ol 19097.

41. “Migraine Statistics,” Migraine.com, https://migraine.com/migraine-statistics/, accessed November 28, 2016.

42. PubMed.gov, https://www.ncbi.nlm.nih.gov/pubmed/?term=migraine+food-i-allergy, accessed November 28, 2016.

43. K. Alpay et al., “Diet Restriction in Migraine, Based on IgG Against Foods: A Clinical Double-blind, Randomised, Cross-over Trial,” Cephalalgia, 30, no. 7 (2010): 829–837, DOI: 10.1177/0333102410361404.

44. C. Di Lorenzo et al., “Migraine Improvement During Short Lasting Ketogene-sis: A Proof-of-Concept Study,” European Journal of Neurology, 22, no. 1 (2015): 170–177, DOI: 10.1111/ene.l2550.

45. C. Di Lorenzo et al., “Diet Transiently Improves Migraine in Two Twin Sisters: Possible Role of Ketogenesis?” Functional Neurology

, 28, no. 4 (2013): 305–308.

46. K. L. Munger et al., “Vitamin D Intake and Incidence of Multiple Sclerosis,” Neurology, 62, no. 1, (2004): 60–65, PMID: 14718698.

47. D. Y. Kim et al., “Inflammation-Mediated Memory Dysfunction and Effects of a Ketogenic Diet in a Murine Model of Multiple Sclerosis,” PLoS One, 7, no. 5 (2012): e35476, DOI: 10.1371/journal.pone.0035476.

48. M. Storoni and G. T. Plant, “The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis,” Multiple Sclerosis International, 2015 (2015): 681289, DOI: 10.1155/2015/681289.

49. Там же.

50. “Non-Alcoholic Fatty Liver Disease,” American Liver Foundation, http://www.liv-erfoundation.org/abouttheliver/info/nafld/, accessed November 28, 2016.

51. S. S. Sundaram, “Pediatric Non-Alcoholic Fatty Liver Disease,” American Liver Foundation, http://www.liverfoundation.org/chapters/rockymountain/doctorsnotes/ pediatricnafld/, accessed November 28, 2016.

52. J. Ma et al., “Sugar-sweetened Beverage, Diet Soda, and Fatty Liver Disease in the Framingham Heart Study Cohorts,” Journal of Hepatology, 63, no. 2 (2015): 462–469, DOI: 10.1016/j.jhep.2015.03.032.

53. J. D. Browning et al., “Short-term Weight Loss and Hepatic Triglyceride Reduction: Evidence of a Metabolic Advantage with Dietary Carbohydrate Restriction,” The American Journal of Clinical Nutrition, 93, no. 5 (2011): 1048–1052. DOI: 10.3945/ajcn.l 10.007674.

54. J. Perez-Guisado and A. Munoz-Serrano, “The Effect of the Spanish Ketogenic Mediterranean Diet on Nonalcoholic Fatty Liver Disease: A Pilot Study,” Journal of Medicinal Food,

 14, no. 7–8 (July-August 2011): 677–680, DOI: 10.1089/ jmf.2011.0075.

55. D. Tendler et al., “The Effect of a Low-Carbohydrate, Ketogenic Diet on Nonalcoholic Fatty Liver Disease: A Pilot Study,” Digestive Diseases and Sciences, 52, no. 2 (February, 2007): 589–593, DOI: 10.1007/sl0620-006-9433-5.

56. P. Kennedy, “The Fat Drug.” The New York Times, March 8, 2014, http://www.ny-times.com/2014/03/09/opinion/sunday/the-fat-drug.html?_r=0, accessed 12/2/16.

57. H.-Y. Kim et al., “Phosphatidylserine-dependent Neuroprotective Signaling Promoted by Docosahexaenoic Acid,” Prostaglandins, Leukotrienes, and Essential Fatty Acids, 82, no. 4–6 (2010): 165–172, DOI: 10.1016/j.plefa.2010.02.025.

58. H.-Y. Kim et al., “N-Docosahexaenoylethanolamide Promotes Development of Hippocampal Neurons,” The Biochemical Journal, 435, no. 2 (2011): 327–336, DOI: 10.1042/BJ20102118.

59. R. Palacios-Pelaez, W. J. Lukiw, and N. G. Bazan, “Omega-3 Essential Fatty Acids Modulate Initiation and Progression of Neurodegenerative Disease,” Molecular Neurobiology, 41, no. 2–3 (June 2010): 367–374, DOI: 10.1007/sl2035-010-8139-z.

60. Interview with J. J. Virgin, http://articles.mercola.com/sites/articles/ar-chive/2014/02/09/fish-oil-brain-health.aspx, accessed 12/2/16.